Tobacco
Compare Stocks
2 / 10Stock Comparison
KAVL vs XXII
Revenue, margins, valuation, and 5-year total return — side by side.
Tobacco
KAVL vs XXII — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Tobacco | Tobacco |
| Market Cap | $238K | $119K |
| Revenue (TTM) | $332K | $19M |
| Net Income (TTM) | $-13M | $-4M |
| Gross Margin | 85.0% | -15.2% |
| Operating Margin | -8.2% | -62.0% |
| Total Debt | $0.00 | $4M |
| Cash & Equiv. | $534K | $7M |
KAVL vs XXII — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Kaival Brands Innov… (KAVL) | 100 | 0.0 | -100.0% |
| 22nd Century Group,… (XXII) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KAVL vs XXII
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KAVL is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta -0.17, yield 100.0%
- -100.0% 10Y total return vs XXII's -100.0%
- Beta -0.17, yield 100.0%, current ratio 1.18x
XXII carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 48.1%, EPS growth 99.9%, 3Y rev CAGR -24.3%
- Lower volatility, beta 1.60, Low D/E 26.7%, current ratio 2.42x
- 48.1% revenue growth vs KAVL's -99.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 48.1% revenue growth vs KAVL's -99.3% | |
| Quality / Margins | -20.5% margin vs KAVL's -39.7% | |
| Dividends | 100.0% yield, vs XXII's 100.0% | |
| Momentum (1Y) | -90.8% vs XXII's -99.8% | |
| Efficiency (ROA) | -14.2% ROA vs KAVL's -208.3%, ROIC -81.4% vs -242.7% |
KAVL vs XXII — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
KAVL vs XXII — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
XXII leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XXII is the larger business by revenue, generating $19M annually — 58.5x KAVL's $332,024. XXII is the more profitable business, keeping -20.5% of every revenue dollar as net income compared to KAVL's -39.7%. On growth, XXII holds the edge at +80.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $332,024 | $19M |
| EBITDAEarnings before interest/tax | -$2M | -$11M |
| Net IncomeAfter-tax profit | -$13M | -$4M |
| Free Cash FlowCash after capex | -$3M | -$8M |
| Gross MarginGross profit ÷ Revenue | +85.0% | -15.2% |
| Operating MarginEBIT ÷ Revenue | -8.2% | -62.0% |
| Net MarginNet income ÷ Revenue | -39.7% | -20.5% |
| FCF MarginFCF ÷ Revenue | -7.9% | -40.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -54.1% | +80.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +94.7% | +58.0% |
Valuation Metrics
XXII leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $238,223 | $118,791 |
| Enterprise ValueMkt cap + debt − cash | -$296,183 | -$3M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 5.10x | 0.01x |
| Price / BookPrice ÷ Book value/share | 1.94x | 0.01x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
XXII leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
XXII delivers a -25.0% return on equity — every $100 of shareholder capital generates $-25 in annual profit, vs $-2 for KAVL. On the Piotroski fundamental quality scale (0–9), XXII scores 4/9 vs KAVL's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.5% | -25.0% |
| ROA (TTM)Return on assets | -2.1% | -14.2% |
| ROICReturn on invested capital | -2.4% | -81.4% |
| ROCEReturn on capital employed | -2.3% | -72.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | — | 0.27x |
| Net DebtTotal debt minus cash | -$534,406 | -$3M |
| Cash & Equiv.Liquid assets | $534,406 | $7M |
| Total DebtShort + long-term debt | $0 | $4M |
| Interest CoverageEBIT ÷ Interest expense | -2550.01x | -10.14x |
Total Returns (Dividends Reinvested)
KAVL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KAVL five years ago would be worth $1 today (with dividends reinvested), compared to $0 for XXII. Over the past 12 months, KAVL leads with a -90.8% total return vs XXII's -99.8%. The 3-year compound annual growth rate (CAGR) favors KAVL at -88.7% vs XXII's -99.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -39.3% | -94.6% |
| 1-Year ReturnPast 12 months | -90.8% | -99.8% |
| 3-Year ReturnCumulative with dividends | -99.9% | -100.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | -100.0% |
| 10-Year ReturnCumulative with dividends | -100.0% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -88.7% | -99.0% |
Risk & Volatility
KAVL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KAVL is the less volatile stock with a -0.17 beta — it tends to amplify market swings less than XXII's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.17x | 1.60x |
| 52-Week HighHighest price in past year | $1.16 | $455.40 |
| 52-Week LowLowest price in past year | $0.01 | $0.67 |
| % of 52W HighCurrent price vs 52-week peak | +1.5% | +0.2% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 15.1 |
| Avg Volume (50D)Average daily shares traded | 22K | 1.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
For income investors, KAVL offers the higher dividend yield at 100.00% vs XXII's 100.00%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +100.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.04 | $25.42 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
XXII leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). KAVL leads in 2 (Total Returns, Risk & Volatility).
KAVL vs XXII: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is KAVL or XXII a better buy right now?
For growth investors, 22nd Century Group, Inc.
(XXII) is the stronger pick with 48. 1% revenue growth year-over-year, versus -99. 3% for Kaival Brands Innovations Group, Inc. (KAVL). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — KAVL or XXII?
Over the past 5 years, Kaival Brands Innovations Group, Inc.
(KAVL) delivered a total return of -100. 0%, compared to -100. 0% for 22nd Century Group, Inc. (XXII). Over 10 years, the gap is even starker: KAVL returned -100. 0% versus XXII's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — KAVL or XXII?
By beta (market sensitivity over 5 years), Kaival Brands Innovations Group, Inc.
(KAVL) is the lower-risk stock at -0. 17β versus 22nd Century Group, Inc. 's 1. 60β — meaning XXII is approximately -1071% more volatile than KAVL relative to the S&P 500.
04Which is growing faster — KAVL or XXII?
By revenue growth (latest reported year), 22nd Century Group, Inc.
(XXII) is pulling ahead at 48. 1% versus -99. 3% for Kaival Brands Innovations Group, Inc. (KAVL). On earnings-per-share growth, the picture is similar: 22nd Century Group, Inc. grew EPS 99. 9% year-over-year, compared to 6. 8% for Kaival Brands Innovations Group, Inc.. Over a 3-year CAGR, XXII leads at -24. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — KAVL or XXII?
22nd Century Group, Inc.
(XXII) is the more profitable company, earning -28. 7% net margin versus -356. 2% for Kaival Brands Innovations Group, Inc. — meaning it keeps -28. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XXII leads at -64. 9% versus -365. 3% for KAVL. At the gross margin level — before operating expenses — KAVL leads at 1037%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — KAVL or XXII?
All stocks in this comparison pay dividends.
Kaival Brands Innovations Group, Inc. (KAVL) offers the highest yield at 100. 0%, versus 100. 0% for 22nd Century Group, Inc. (XXII).
07Is KAVL or XXII better for a retirement portfolio?
For long-horizon retirement investors, Kaival Brands Innovations Group, Inc.
(KAVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 17), 100. 0% yield). 22nd Century Group, Inc. (XXII) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KAVL: -100. 0%, XXII: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between KAVL and XXII?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KAVL is a small-cap income-oriented stock; XXII is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Consumer Defensive
- Market Cap > $20B
- Revenue Growth > 40%
- Dividend Yield > 40.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.